MPLX LP vs GeneDx Holdings Corp — how do they compare? MPLX LP trades at $56.75 (market cap $57.97B), while GeneDx Holdings Corp trades at $61.92 (market cap $1.80B). The key difference: MPLX LP is far larger — about 32.2× GeneDx Holdings Corp's market cap, and MPLX LP pays a 7.54% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.
| MPLX | WGS | |
|---|---|---|
Market Cap | $57.97B | $1.80B |
Sector | Technology | Technology |
52-Week High | $59.17 | $167.51 |
52-Week Low | $47.80 | $34.51 |
Enterprise Value | $82.60B | $1.80B |
Dividend Yield | 7.54% | — |
Trailing returns across standard periods
Latest headlines on both assets
MPLX LP is a Master Limited Partnership (MLP) formed by Marathon Petroleum Corporation (MPC). It is a diversified, growth-oriented company primarily engaged in the gathering, processing, and transportation of natural gas and natural gas liquids (NGLs), as well as the transportation, storage, and distribution of crude oil and refined petroleum products. MPLX owns and operates a network of midstream energy infrastructure assets, providing essential services to the energy industry across the United States.
Read more on MPLX →GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →